Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yangzhou Sanyao Pharmaceutical is a prominent Chinese pharmaceutical manufacturer based in Yangzhou, Jiangsu Province, and operates as a subsidiary of the China Meheco Group. The company specializes in the development, production, and distribution of a wide range of chemical drug preparations and active pharmaceutical ingredients (APIs). Its extensive product portfolio covers critical therapeutic areas including cardiovascular diseases, infectious diseases, and metabolic disorders, with high-volume products such as amlodipine, captopril, and metformin. Yangzhou Sanyao maintains modern, GMP-certified facilities capable of producing various dosage forms like tablets, capsules, and granules for both domestic and international markets. With a history dating back to 1970, the company has established itself as a reliable provider of essential generic medicines within the Chinese healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangzhou Sanyao Pharmaceutical.